This This Is Why pharmacology review examines the evidence-based pharmacologic and behavioral strategies for smoking cessation. The episode explores how combining medication with behavioral interventions can substantially improve abstinence rates and long-term success.

‍

The review begins with the clinical relevance of smoking cessation, outlines the 5 A’s (Ask, Advise, Assess, Assist, Arrange) and 5 R’s (Relevance, Risks, Rewards, Roadblocks, Repeat), and then analyzes first-line pharmacologic options—bupropion, nicotine replacement therapy (NRT), and varenicline—alongside alternative agents such as nortriptyline and clonidine. Each therapy is discussed in terms of mechanism, dosing, timing in relation to quit date, advantages, disadvantages, contraindications, and monitoring requirements.

‍

Chapters:

00:00 Introduction & Why Smoking Cessation Matters Clinically
00:00:33 Epidemiology of Tobacco Use & Population Health Impact
00:01:54 Behavioral Interventions: 5 A’s Framework & CBT Integration
00:04:54 First-Line Smoking Cessation Pharmacotherapies Overview
00:05:46 Bupropion: Mechanism, Clinical Use & Safety Considerations
00:08:19 Nicotine Replacement Therapy (NRT): Forms, Dosing & Clinical Pearls
00:13:21 Varenicline: Mechanism, Efficacy & Patient Selection
00:22:30 Treatment Optimization: Side Effects, Duration, Relapse Prevention

‍

#SmokingCessation #pharmacologymadeeasy #medicaleducation #pharmacyeducation #nursingeducation

‍

Disclaimer:
This content is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard in this content.